WTA
WGS icon

Washington Trust Advisors’s GeneDx Holdings WGS Stock Holding History

Washington Trust Advisors’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-41
Closed -$4.42K – 695
2025
Q3 		$4.42K Buy
41
+15
+58% +$1.63K ﹤0.01% 627
2025
Q2 		$2.4K Hold
26
– – ﹤0.01% 603
2025
Q1 		$2.3K Buy
+26
New +$2.26K ﹤0.01% 607

Other funds holding WGS

Corvex Management
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Summit Partners Public Asset Management
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Washington Trust Advisors's WGS Position: Q4 2025 in Review

Washington Trust Advisors sold out of GeneDx Holdings (WGS) in Q4 2025, closing a stake of 41 shares — an estimated $4.42K sold.

Washington Trust Advisors first reported a position in WGS in Q1 2025 and held it in 3 quarters. The position peaked at $4.42K in Q3 2025. 287 funds tracked by Wall St. Rank hold WGS as of Q4 2025.

  • Washington Trust Advisors reported no remaining GeneDx Holdings position as of Q4 2025 after selling out during the quarter.
  • Washington Trust Advisors sold 41 GeneDx Holdings shares in Q4 2025, an estimated $4.42K.
  • Washington Trust Advisors first reported a position in GeneDx Holdings in Q1 2025 and held it in 3 quarters.
  • Washington Trust Advisors's GeneDx Holdings position peaked at $4.42K in Q3 2025.
  • 287 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2025.

Based on Washington Trust Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.